Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02397356
Recruitment Status : Withdrawn (Lack of study personnel)
First Posted : March 24, 2015
Last Update Posted : August 28, 2018
Sponsor:
Information provided by (Responsible Party):
Tampere University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020
Publications:
Christensen K, Rogers E, Green GA, et al. Safety and efficacy of intranasal ketamine for acute postoperative pain. Acute Pain. 2007;9(4):183-192.
European Medicines Agency. Guideline for good clinical practice 2002. www.ema.com.eu. Accessed 8/1, 2012.